505 related articles for article (PubMed ID: 35574025)
1. The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.
Ritch SJ; Telleria CM
Front Endocrinol (Lausanne); 2022; 13():886533. PubMed ID: 35574025
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix in high-grade serous ovarian cancer: Advances in understanding of carcinogenesis and cancer biology.
Brown Y; Hua S; Tanwar PS
Matrix Biol; 2023 Apr; 118():16-46. PubMed ID: 36781087
[TBL] [Abstract][Full Text] [Related]
3. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.
Yasui H; Kajiyama H; Tamauchi S; Suzuki S; Peng Y; Yoshikawa N; Sugiyama M; Nakamura K; Kikkawa F
Clin Exp Metastasis; 2020 Feb; 37(1):145-158. PubMed ID: 31541326
[TBL] [Abstract][Full Text] [Related]
4. Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles.
Yousefi M; Dehghani S; Nosrati R; Ghanei M; Salmaninejad A; Rajaie S; Hasanzadeh M; Pasdar A
Cell Oncol (Dordr); 2020 Aug; 43(4):515-538. PubMed ID: 32418122
[TBL] [Abstract][Full Text] [Related]
5. The Many Microenvironments of Ovarian Cancer.
Micek HM; Visetsouk MR; Fleszar AJ; Kreeger PK
Adv Exp Med Biol; 2020; 1296():199-213. PubMed ID: 34185294
[TBL] [Abstract][Full Text] [Related]
6. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
[TBL] [Abstract][Full Text] [Related]
7. P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions.
Usui A; Ko SY; Barengo N; Naora H
Mol Cancer Res; 2014 Apr; 12(4):504-13. PubMed ID: 24448686
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.
Weidle UH; Birzele F; Kollmorgen G; Rueger R
Cancer Genomics Proteomics; 2016 11-12; 13(6):407-423. PubMed ID: 27807064
[TBL] [Abstract][Full Text] [Related]
9. Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components.
Uno K; Iyoshi S; Yoshihara M; Kitami K; Mogi K; Fujimoto H; Sugiyama M; Koya Y; Yamakita Y; Nawa A; Kanayama T; Tomita H; Enomoto A; Kajiyama H
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457198
[TBL] [Abstract][Full Text] [Related]
10. Exosomes from Human Omental Adipose-Derived Mesenchymal Stem Cells Secreted into Ascites Promote Peritoneal Metastasis of Epithelial Ovarian Cancer.
Qu Q; Liu L; Cui Y; Chen Y; Wang Y; Wang Y
Cells; 2022 Oct; 11(21):. PubMed ID: 36359787
[TBL] [Abstract][Full Text] [Related]
11. Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.
Klymenko Y; Kim O; Stack MS
Cancers (Basel); 2017 Aug; 9(8):. PubMed ID: 28792442
[TBL] [Abstract][Full Text] [Related]
12. Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells.
Nakamura K; Sawada K; Kinose Y; Yoshimura A; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Morishige KI; Kurachi H; Lengyel E; Kimura T
Mol Cancer Res; 2017 Jan; 15(1):78-92. PubMed ID: 27758876
[TBL] [Abstract][Full Text] [Related]
13. SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids.
Ziske MA; Pettee KM; Khaing M; Rubinic K; Eisenmann KM
Biochem Biophys Res Commun; 2016 Mar; 472(1):33-9. PubMed ID: 26898799
[TBL] [Abstract][Full Text] [Related]
14. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.
Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG
Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027
[TBL] [Abstract][Full Text] [Related]
15. Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids.
He M; Wang D; Zou D; Wang C; Lopes-Bastos B; Jiang WG; Chester J; Zhou Q; Cai J
Oncotarget; 2016 Dec; 7(52):86374-86387. PubMed ID: 27863439
[TBL] [Abstract][Full Text] [Related]
16. Immune Tumor Microenvironment in Ovarian Cancer Ascites.
Almeida-Nunes DL; Mendes-Frias A; Silvestre R; Dinis-Oliveira RJ; Ricardo S
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142615
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review.
Dhaliwal D; Shepherd TG
Clin Exp Metastasis; 2022 Apr; 39(2):291-301. PubMed ID: 34822024
[TBL] [Abstract][Full Text] [Related]
18. Chondroitin Sulfate Proteoglycan 4 Provides New Treatment Approach to Preventing Peritoneal Dissemination in Ovarian Cancer.
Uno K; Koya Y; Yoshihara M; Iyoshi S; Kitami K; Sugiyama M; Miyamoto E; Mogi K; Fujimoto H; Yamakita Y; Wang X; Nawa A; Kajiyama H
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338902
[TBL] [Abstract][Full Text] [Related]
19. The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models.
Tadić V; Zhang W; Brozovic A
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189052. PubMed ID: 38097143
[TBL] [Abstract][Full Text] [Related]
20. Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.
Peters PN; Schryver EM; Lengyel E; Kenny H
J Vis Exp; 2015 Dec; (106):e53541. PubMed ID: 26780294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
